Clinical TrialID 2676

Vitamin C & Thiamine to Treat Sepsis and Septic Shock

NCT03592277

Sepsis|Septic Shock

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2676
Evidence Id
2676
Core Evidence Id
2676
Source Clinical Trial Id
2668
Herb2 Clinical Trial Id
HBCT002668
Nct Id
NCT03592277
Title
Vitamin C & Thiamine to Treat Sepsis and Septic Shock
Status
Completed
Phase
Phase 2
Study Result
Yes
Study Condition
Sepsis|Septic Shock
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Intervention
DRUG: Vitamin C|DRUG: Vitamin B1
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Quadruple
Intervention Purpose
Treatment
Gender
All
Age
Adult, Older_Adult
Enrollment
120
Outcome Measure
Mortality Rates, All-cause mortality from time of enrollment/treatment to 30 days post hospital discharge (up to 87 days), From time of treatment to 30 days post hospital discharge, up to 87 days.
Sponsor Collaborator
Trinity Health Of New England
Funded By
OTHER
Location
Saint Francis Hospital and Medical Center, Hartford, Connecticut, 06105, United States
Other Id
SF-18-42
Start Date
2018-09-14
Primary Completion Date
2021-02-22
Completion Date
2021-02-22
First Posted
2018-07-19
Results First Posted
2022-09-28
Last Update Posted
2022-09-28
Study Document
Study Protocol and Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/77/NCT03592277/Prot_SAP_000.pdf
Study Url
https://clinicaltrials.gov/study/NCT03592277
Title Cn
Title En
Vitamin C & Thiamine to Treat Sepsis and Septic Shock
Bilingual Status
semi_complete